Correlation Between Ford and Salarius Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ford and Salarius Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ford and Salarius Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ford Motor and Salarius Pharmaceuticals, you can compare the effects of market volatilities on Ford and Salarius Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ford with a short position of Salarius Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ford and Salarius Pharmaceuticals.
Diversification Opportunities for Ford and Salarius Pharmaceuticals
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Ford and Salarius is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Ford Motor and Salarius Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Salarius Pharmaceuticals and Ford is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ford Motor are associated (or correlated) with Salarius Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Salarius Pharmaceuticals has no effect on the direction of Ford i.e., Ford and Salarius Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ford and Salarius Pharmaceuticals
Taking into account the 90-day investment horizon Ford is expected to generate 3.66 times less return on investment than Salarius Pharmaceuticals. But when comparing it to its historical volatility, Ford Motor is 9.52 times less risky than Salarius Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Salarius Pharmaceuticals is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 149.00 in Salarius Pharmaceuticals on December 24, 2024 and sell it today you would lose (53.00) from holding Salarius Pharmaceuticals or give up 35.57% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Ford Motor vs. Salarius Pharmaceuticals
Performance |
Timeline |
Ford Motor |
Salarius Pharmaceuticals |
Ford and Salarius Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ford and Salarius Pharmaceuticals
The main advantage of trading using opposite Ford and Salarius Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ford position performs unexpectedly, Salarius Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Salarius Pharmaceuticals will offset losses from the drop in Salarius Pharmaceuticals' long position.The idea behind Ford Motor and Salarius Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Salarius Pharmaceuticals vs. Akari Therapeutics PLC | Salarius Pharmaceuticals vs. Nutriband | Salarius Pharmaceuticals vs. SAB Biotherapeutics | Salarius Pharmaceuticals vs. GeoVax Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |